Secukinumab‐induced scar sarcoidosis in a patient with plaque psoriasis
Sign Up to like & getrecommendations! Published in 2022 at "Australasian Journal of Dermatology"
DOI: 10.1111/ajd.13799
Abstract: Pemigatinib is a Fibroblast grow factor receptor (FGFR) inhibitor used since 2020 as a second line in cholangiocarcinomas and advanced urothelial carcinomas. Dermatological adverse effects, like nail toxicity, have been reported in the phase 2… read more here.
Keywords: scar sarcoidosis; secukinumab induced; dermatology; patient ... See more keywords
Incidence of allopurinol-induced severe cutaneous adverse drug reaction in Malaysia.
Sign Up to like & getrecommendations! Published in 2022 at "British journal of clinical pharmacology"
DOI: 10.1111/bcp.15327
Abstract: INTRODUCTION Allopurinol is known to cause severe cutaneous adverse drug reactions (SCAR) in Malaysia. However, the incidence of allopurinol-induced SCAR is unknown. Therefore, we aimed to determine the incidence of allopurinol-induced SCAR in Malaysia over… read more here.
Keywords: induced scar; incidence allopurinol; allopurinol; allopurinol induced ... See more keywords